Table 1 Demographic, pregnancy and birth characteristics of the BioBAYB study participants.

From: Predicting labor onset relative to the estimated date of delivery using smart ring physiological data

 

n = 31 Induced Labor or Planned Cesarean Before EDD n (%)

n = 39 Spontaneous Labor Before EDD n (%)

n = 48 Birth after EDD n (%)

Test Two-tailed t2

p

Age, years, mean (SD)

32.7 (4.3)

32.5 (4.3)

32.6 (3.8)

0.07

0.94

Self-reported race/ethnicity/ancestry (may have selected more than one)

 White/European

29 (90.6)

32 (82.1)

46 (95.8)

4.41

0.04

 Asian or Pacific Islands

2 (6.3)

3 (7.7)

6 (8.4)

  

 Latin American/ Hispanic

2 (6.3)

7 (17.9)

1 (2.1)

  

 Black/African

0 (0)

2 (5.1)

0 (0)

  

 Other/Chose not to answer

1 (3.1)

2 (5.1)

1 (2.1)

  

Gestational age at enrollment, weeks

29.4 (3.1)

29.9 (2.8)

31.2 (2.6)

2.14

0.04

Nulliparous

26 (81.3)

18 (46.2)

24 (50.0)

0.13

0.72

Pre-pregnancy body mass index kg/m2

24.6 (4.3)

23.9 (4.1)

23.7 (4.1)

−0.23

0.82

Medication/substances in pregnancy

 Daily aspirin

5 (15.6)

4 (10.3)

7 (14.6)

0.36

0.55

 Anti-depressant (SSRI)

4 (12.5)

4 (10.3)

3 (6.3)

0.47

0.49

 Iron supplement

8 (25.0)

10 (25.6)

21 (43.8)

3.08

0.08

 Prenatal multivitamin

30 (93.8)

39 (100.0)

47 (97.9)

0.82

0.37

 Fish oil supplement

13 (40.6)

22 (56.4)

18 (37.5)

3.10

0.08

 Acetaminophen >3 times

9 (28.1)

5 (12.8)

9 (18.8)

0.56

0.45

 Thyroid medication

0 (0)

4 (10.3)

5 (10.4)

0.0006

0.98

 Sleep aids

5(15.6)

2 (5.1)

4 (8.3)

0.34

0.56

Edinburgh Postnatal Depression (EPDS)

6.6 (3.2)

5.6 (2.5)

5.3 (2.2)

−0.65

0.51

Generalized Anxiety Disorder (GAD 7)

3.5 (3.30

3.2 (2.5)

2.4 (1.9)

−1.58

0.12

Febrile illness, influenza, SARS-CoV-2

4 (12.5)

7 (17.5)

14 (29.2)

2.31

0.13

Pregnancy conditions after enrollment

 Hypertension or preeclampsia

4 (12.9)

2 (5.0)

2 (4.2)

0.05

0.83

 Oligohydramnios/polyhydramnios

2 (6.3)

0 (0)

0 (0)

  

 Fetal growth restriction

4 (12.5)

1 (2.5)

1 (2.1)

0.02

0.88

Weight gained during pregnancy (lbs.)

36.9 (11.9)

34.1 (12.9)

34.1 (10.8)

  

Labor onset

 Spontaneous labor

0 (0)

39 (100)

31 (64.6)

17.17

<0.001

 Labor induction

27 (87.5)

0 (0)

17 (35.4)

  

 Pre-labor rupture of membranes

5

 

2

  

 Medical/obstetric condition

20

 

15

  

 Elective

3

 

1

  

 No Labor: Cesarean before labor

4 (12.5)

0 (0)

0 (0)

  

Location of birth

 Hospital

32 (100)

30 (76.9)

40 (83.3)

1.27

0.53

 Home (planned/unplanned)

 

5 (13.8)*

6 (12.5)

  

 Freestanding birth center

 

4 (10.3)

2 (4.2)

  

Mode of birth

 Vaginal birth

21 (67.4)

32 (82.1)

36 (75.0)

1.41

0.49

 Assisted vaginal birth

1 (3.1)

1 (2.6)

4 (8.3)

  

 Cesarean

9 (29.1)

6 (15.4)

8 (16.7)

  

Duration of labor, hours (mean, SD)

14.1 (12.1)

19.0 (17.7)

16.3 (12.0)

−0.68

0.49

Infant weight, lbs. (mean, SD)

7.0 (0.9)

7.5 (0.9)

8.1 (1.0)

2.75

0.007

Gestational age birth, weeks (mean, SD)

38.7 (1.0)

38.9 (1.1)

40.8 (0.55)

10.44

<0.001

Labor and birth complications

 Umbilical cord prolapse

1 (2.5)

1 (2.5)

0 (0)

  

 Fever/infection

4 (12.5)

2 (5)

1 (2.1)

0.59

0.44

 Received antibiotics during labor

6 (19.3)

3 (7.7)

11 (22.9)

3.69

0.06

 Postpartum hemorrhage

2 (6.3)

2 (5.1)

4 (8.3)

0.34

0.56

 Neonatal intensive care unit

4 (12.5)

6 (15.4)

3 (6.3)

1.94

0.16

  1. Data grouped by timing of delivery relative to the Estimated Delivery Date (EDD) of 40.0 weeks of gestation. Bivariate tests, p-values compare spontaneous labor (n = 39) prior to the EDD to births occurring after the EDD (n = 48). No differences were observed in insurance provider, fetal sex or educational attainment.
  2. SSRI selective serotonin reuptake inhibitor.
  3. *n = 1 home birth was unplanned.